All stories tagged :

Pr Newswire

4DMT to Participate in Chardan’s 9th Annual Genetic Medicines Conference

Tháng 10 14

ROHM’s New “TRCDRIVE pack (TM)” with 2-in-1 SiC Molded Module: Significantly...

1 năm ago

XTransfer and Banking Circle Announce Strategic Partnership

1 năm ago

Alvotech and STADA add to Strategic Alliance through Denosumab Partnership

1 năm ago

Alvotech and STADA add to strategic alliance through denosumab partnership

1 năm ago

Bright Peak Therapeutics Announces $90 Million in Series C Financing to...

1 năm ago

NIRA Dynamics’ Wheel Safety solutions would annually prevent hundreds of accidents...

1 năm ago

GN to gradually wind-down its Elite and Talk product lines. Strong...

1 năm ago

Essential Pharma reaches agreement with AGC Biologics for late phase clinical...

1 năm ago

ITC final initial determination Ruled in favor of Hugel (no violation...

1 năm ago

Global Registrational Phase III Study of Olverembatinib for the Treatment of...

1 năm ago

1 2 3 … 757 758 759 760 761 762 763 Page 760 of 763

Featured

Opus Genetics to Participate in Chardan’s 9th Annual Genetic Medicines Conference

2 giờ ago

Hawx Services Celebrates Serving 14 States Across Nationwide

2 giờ ago

AICB Launches FSF Xcel: Malaysia’s First Industry-Wide Skills Assessment Platform to...

2 giờ ago

Morgan Stanley Raises JOYY (JOYY.US) Target Price from US$40 to US$62...

2 giờ ago

2 giờ ago

Opus Genetics to Participate in Chardan’s 9th Annual Genetic Medicines Conference

RESEARCH TRIANGLE PARK, N.C., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic disorders, announced today that Ash...